Investor Type | Firm |
Industries | IT (& TMT) • BioTech • HealthTech (& Fitness) • Web Security (& Privacy) • Life Science |
Investing | United States |
BlueIO is an investment firm located in Boston, Massachusetts, that strives to build a more secure, sustainable, and healthier world by forming, investing in, and building the next generation of purpose-driven companies. With over two decades of experience, their mission encompasses creating global companies that address the world's most critical issues through deep technological innovation and a commitment to long-term results. BlueIO adopts a 'Builder Capitalism' philosophy, focusing on world-changing technologies and immersing themselves in the operational aspects of the businesses they support. They have a history of founding, investing in, and scaling market-leading companies, and their investment approach is centered around several key themes:Securing our future: BlueIO invests in creating proactive, resilient cyber security solutions to address the rising number of cyberattacks.Sustaining the world: The firm targets investments in sustainable models for living that consider health, communities, and the planet as one, with the goal of scaling and offering fresh, natural food and nutrients.Saving lives: By embracing advances in biology, chemistry, physics, and technology, BlueIO backs personalized and precision medicine ventures, aiming to make new treatments and methods more accessible.Empowering communities: The team believes in the power of human connection for social, economic, and environmental progress and invests in solutions that help communities, families, and organizations create a better future.With over $1.2 billion of value in companies they've co-founded, a 300% value appreciation since 2018, and more than 1600 patents among their companies, BlueIO illustrates a strong record of success. The firm was founded by Dave Furneaux in 2012 and is supported by a team of 40 builders, including President Jan Haas. They finance companies throughout their lifecycles, from the founding stages to pre-IPO, leveraging their deep technological and operational expertise to impact a unique set of market opportunities at the intersection of purpose and profit. Their portfolio includes companies like Mend, Lufa Farms, Virsec Systems, Lumicell, CyberSaint, and Greenlight Biosciences.